Profound Medical Corp faced a notable decline in its stock price during yesterday's trading session.
In a challenging day for investors, Profound Medical Corp (PRN.TO) saw its stock price decrease by 3.62%, closing at CA$8.25. This drop is part of a broader trend affecting the company, which has struggled to maintain momentum amidst shifting market conditions.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$301.46M
52W high
$12.40
52W low
$6.52
1W change
+4.17%
Beta
0.50
Analyst Price Targets
Based on analyst covering PRN · as of Sep 17, 2026
Wall Street analysts forecast PRN stock price to rise 203.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+203.4% Upside
Current Price
C$8.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
57.0%
Annualized
90-Day Vol
53.5%
Annualized
Trend (90d)
-34.2%
Annualized drift
90d Mean
C$7.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.92 | C$6.51 – C$9.64 |
| 60 trading days | C$7.60 | C$5.76 – C$10.04 |
| 90 trading days | C$7.30 | C$5.19 – C$10.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Profound Medical Corp navigates recent management changes and the ongoing development of its medical technologies.
Bull case
Despite the decline, Profound Medical is actively working on innovative solutions in the medical field. These efforts could lead to future growth opportunities if the company successfully brings its TULSA-PRO® and Sonalleve® systems to market.
Bear case
The recent changes in management and the absence of significant news may raise concerns about the company's strategic direction. This uncertainty can contribute to investor hesitation and affect stock performance.
Recent Performance Overview
Yesterday's trading session marked a significant downturn for Profound Medical Corp, which fell by 3.62%. This decline highlights the ongoing volatility in the stock, raising questions about the company's strategic direction following recent management changes.
Advertisement
Management Changes Impacting Investor Confidence
The recent promotion of Matthew Sobczyk to Interim Chief Financial Officer, alongside the appointment of Richard Fabian as President, may have contributed to the uncertainty surrounding Profound Medical. Investors often react to leadership shifts, and the lack of clear communication regarding future strategies could be weighing on stock performance.
Looking Ahead: Potential Opportunities
Despite the recent drop, Profound Medical continues to focus on the commercialization of its TULSA-PRO® and Sonalleve® systems. If the company can successfully navigate its leadership transitions and deliver on its growth promises, there may still be potential for recovery in the stock price.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
